Yatsenko Alexander N, Georgiadis Andrew P, Röpke Albrecht, Berman Andrea J, Jaffe Thomas, Olszewska Marta, Westernströer Birgit, Sanfilippo Joseph, Kurpisz Maciej, Rajkovic Aleksandar, Yatsenko Svetlana A, Kliesch Sabine, Schlatt Stefan, Tüttelmann Frank
From the Departments of Obstetrics, Gynecology, and Reproductive Sciences (A.N.Y., A.P.G., J.S., A. Rajkovic, S.A.Y.) and Urology (T.J.), University of Pittsburgh School of Medicine, and the Department of Biological Sciences, University of Pittsburgh, Kenneth P. Dietrich School of Arts and Sciences (A.J.B.) - all in Pittsburgh; the Institute of Human Genetics (A. Röpke, F.T.) and Center of Reproductive Medicine and Andrology (B.W., S.K., S.S.), University of Münster, Münster, Germany; and the Department of Reproductive Biology and Stem Cells, Institute of Human Genetics, Polish Academy of Sciences, Poznań (M.O., M.K.).
N Engl J Med. 2015 May 28;372(22):2097-107. doi: 10.1056/NEJMoa1406192. Epub 2015 May 13.
The genetic basis of nonobstructive azoospermia is unknown in the majority of infertile men.
We performed array comparative genomic hybridization testing in blood samples obtained from 15 patients with azoospermia, and we performed mutation screening by means of direct Sanger sequencing of the testis-expressed 11 gene (TEX11) open reading frame in blood and semen samples obtained from 289 patients with azoospermia and 384 controls.
We identified a 99-kb hemizygous loss on chromosome Xq13.2 that involved three TEX11 exons. This loss, which was identical in 2 patients with azoospermia, predicts a deletion of 79 amino acids within the meiosis-specific sporulation domain SPO22. Our subsequent mutation screening showed five novel TEX11 mutations: three splicing mutations and two missense mutations. These mutations, which occurred in 7 of 289 men with azoospermia (2.4%), were absent in 384 controls with normal sperm concentrations (P=0.003). Notably, five of those TEX11 mutations were detected in 33 patients (15%) with azoospermia who received a diagnosis of azoospermia with meiotic arrest. Meiotic arrest in these patients resembled the phenotype of Tex11-deficient male mice. Immunohistochemical analysis showed specific cytoplasmic TEX11 expression in late spermatocytes, as well as in round and elongated spermatids, in normal human testes. In contrast, testes of patients who had azoospermia with TEX11 mutations had meiotic arrest and lacked TEX11 expression.
In our study, hemizygous TEX11 mutations were a common cause of meiotic arrest and azoospermia in infertile men. (Funded by the National Institutes of Health and others.).
在大多数不育男性中,非梗阻性无精子症的遗传基础尚不清楚。
我们对15例无精子症患者的血液样本进行了阵列比较基因组杂交检测,并通过对289例无精子症患者和384例对照的血液及精液样本中睾丸表达11基因(TEX11)开放阅读框进行直接桑格测序来进行突变筛查。
我们在Xq13.2染色体上鉴定出一个99kb的半合子缺失,该缺失涉及TEX11的三个外显子。这种缺失在2例无精子症患者中是相同的,预测减数分裂特异性孢子形成结构域SPO22内缺失79个氨基酸。我们随后的突变筛查发现了5个新的TEX11突变:3个剪接突变和2个错义突变。这些突变发生在289例无精子症男性中的7例(2.4%),在384例精子浓度正常的对照中未出现(P=0.003)。值得注意的是,在33例(15%)被诊断为减数分裂停滞性无精子症的患者中检测到了其中5个TEX11突变。这些患者的减数分裂停滞类似于Tex11缺陷雄性小鼠的表型。免疫组织化学分析显示,在正常人类睾丸中,TEX11在晚期精母细胞以及圆形和细长形精子细胞中呈特异性细胞质表达。相比之下,患有TEX11突变的无精子症患者的睾丸出现减数分裂停滞且缺乏TEX11表达。
在我们的研究中,半合子TEX11突变是不育男性减数分裂停滞和无精子症的常见原因。(由美国国立卫生研究院等资助。)